Skip to content

Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control

Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03613688
Enrollment
28
Registered
2018-08-03
Start date
2018-09-20
Completion date
2019-07-31
Last updated
2018-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Metabolism Disorders

Brief summary

This is a randomized, controlled, cross-over study on the effects of consumption of Deepure puerh tea extract (PTE) on glucose tolerance and metabolic markers.

Detailed description

The study will involve consuming three different doses: 1 gram, 1.5 grams, and 2 grams, and will be given in warm water, with a bland meal. The effects on glucose and insulin after consumption will be evaluated.The subjects will be randomly assigned to one of four groups with different sequences.

Interventions

DIETARY_SUPPLEMENTDeepure

Pu'erh Tea extract

Sponsors

Natural Immune Systems Inc
CollaboratorOTHER
Tasly Pharmaceuticals, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women; * Aged 18-70 years; * BMI between 20-30; * Fasting blood glucose at screening between 71-125 mg/dL. both inclusive.

Exclusion criteria

* Taking dietary supplements judged to interfere with the effects of Deepure on glucose metabolism (for example: cinnamon extract; chromium picolinate; mulberry extract; bitter melon extract, green tea extracts, black tea extracts, pu-erh tea); * Participation in other clinical trials, involving an investigational product or lifestyle change, during the last month; * Participation in another research study during this trial, involving an investigational product or lifestyle change; Taking prescription medication known to affect glucose metabolism; * Taking over-the-counter medication known to affect glucose metabolism; * Drinking 3 or more cups of tea daily; * Unwilling to abstain from drinking tea for 24 hours before clinic visits; (if a person drinks tea within 24 hours of a clinic visit, the person's visit will be re-scheduled); * Consuming 2 or more drinks of alcohol per day; * Unwilling to abstain from drinking alcohol for 10 hours before clinic visits; * Diagnosed with diabetes Type I; Taking medication for diabetes Type II; * Diagnosed with the thyroid disorder Hashimoto's disease; * Past major surgery to your stomach or intestines (minor surgery not a problem such as hernia repair, appendix removal, gallbladder removal); * Currently taking cholesterol-lowering medication (for example: statins); * Currently taking coumadin; * Major trauma within the past 6 months; * Major surgery within the past 6 months; * Severe chronic infectious disease (such as HIV, chronic hepatitis); * Active depression; * Self-reported eating disorders; * History of drug abuse during past two years; * Currently going through intense stressful events or life changes; * Women of child-bearing potential: Pregnant, breast-feeding, or trying to become pregnant; * Women of child-bearing potential: Not using effective contraception; * Food allergies or sensitivities to tea.

Design outcomes

Primary

MeasureTime frameDescription
Post-prandial glucose responseFrom baseline to 30, 60, 90, 120, and 180 minutesChange in blood glucose leve after consuming test meal with and without Pu'er tea

Countries

United States

Contacts

Primary ContactGitte Jensen
gitte@nislabs.com(541) 884-0112

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026